Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/61185
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRanade, Prasanna B-
dc.contributor.authorNavale, Dinesh N-
dc.contributor.authorZote, Santosh W-
dc.contributor.authorKulal, Dnyaneshwar K-
dc.contributor.authorWagh, Swapnil J-
dc.date.accessioned2023-01-10T09:21:30Z-
dc.date.available2023-01-10T09:21:30Z-
dc.date.issued2023-01-
dc.identifier.issn0975-0959 (Online); 0301-1208 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/61185-
dc.description55-57en_US
dc.description.abstractCurrently, there is no approved drug to combat dengue. Various quinoline derivatives are known for potential antimalarial, antiviral activities, etc. In the present work docking between 4-Amino-7-Chloroquinoline analogs was performed with dengue virus NS2B/NS3 protease using CB dock, a web server. Lys74, Ile165, Val147, Asn152, Asn167, Trp83 and Leu149 amino acid residues were found to be in contact with designed 4-Amino-7-Chloroquinoline analogs. Different modes of binding like hydrogen bonding, hydrophobic interactions, etc with designed compounds improve potential anti-dengue characteristics in silico. ADME results are in acceptable range.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJBB Vol.60(01) [January 2023]en_US
dc.subject2FOMen_US
dc.subjectADMEen_US
dc.subjectAmino Acidsen_US
dc.subjectDrug designen_US
dc.subjectQuinolineen_US
dc.titleBlind docking of 4-Amino-7-Chloroquinoline analogs as potential dengue virus protease inhibitor using CB Dock a web serveren_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijbb.v60i1.64604en_US
Appears in Collections:IJBB Vol.60(01) [January 2023]

Files in This Item:
File Description SizeFormat 
IJBB 60(01) 55-57.pdf525.29 kBAdobe PDFView/Open
IJBB 60(01) 55-57 Suppl.pdf7.08 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.